Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07049952 · ClinicalTrials.gov registry record · Phase 2

BabySTrong II taVNS Feeding Trial

A Phase 2 study of Feeding Delays and Neonates and Term Infants, sponsored by Medical University of South Carolina.

Recruiting
Registry status
Phase 2
Development phase
88
Enrollment target
1
Study location

NCT07049952: Recruiting Phase 2 study of Feeding Delays and Neonates and Term Infants, sponsored by Medical University of South Carolina.

NCT07049952 is a Phase 2 study of Feeding Delays and Neonates and Term Infants that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 88 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07049952, a Phase 2 study of Feeding Delays and Neonates and Term Infants, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
Phase 2
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

The long-term goal of this project is to develop a therapy to assist pre-term and term infants with brain injury overcome difficulties in learning to feed so that infants may be discharged home with their families and avoid the burdens of of a gastrostomy tube (G-tube) or prolonged home nasogastric feeding. Few other therapies exist for infants who are not making progress with feeding volumes at term age. To tackle this problem, we took the novel approach of pairing non-invasive nerve stimulation of the vagus nerve at the ear (taVNS) stimulation with the motor skills of feeding. In our pilot studies, 54% (19 out of 35) infants with feeding delays whose families were in discussions for G-tube placement, reached full oral feeds within 2 weeks, and infants who did not reach full feeds still improved their daily oral feeding volumes. Infants who got to full feeds showed stronger and more complex brain circuits associated with feeding motor skills. With this trial we will test the BabySTrong taVNS feeding system in a multicenter, randomized, controlled, blinded trial to show how well this feeding system works in improving the daily feeding volumes, the days to full oral feeds, and/or the number of infants who avoid G-tube/ home NG placement, and increasing connections in brain circuits. If this groundbreaking new approach to infant feeding is successful, we may decrease how long infants are in the hospital, costs with Gtubes and home NG feeds, and family and care provider burdens. The findings from this proposal will be used in our FDA application for the BabySTrong feeding system.

Primary Outcome

number of participants achieving full oral feeds receiving ANY active taVNS (groups T+NT), vs Control (IDM combined with Non IDM control groups), based on the randomized assignment.

Interventions

  • DEVICE taVNS
  • COMBINATION_PRODUCT NAC and taVNS
  • DEVICE inactive taVNS
  • COMBINATION_PRODUCT sterile water and inactive taVNS

Study Locations (1)

South Carolina

  • Shawn Jenkins Children's Hospital, Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2025-11-16
Est. Completion 2027-12-30
Phase Phase 2

What NCT07049952 shows while recruiting

NCT07049952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (34% lower).

The record links to 2 conditions, with Feeding Delays appearing as the primary indexed condition, and to 4 interventions - of which taVNS is the first listed.

NCT07049952 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT07049952 about?

NCT07049952 is a clinical study titled "BabySTrong II taVNS Feeding Trial". The long-term goal of this project is to develop a therapy to assist pre-term and term infants with brain injury overcome difficulties in learning to feed so that infants may be discharged home with their families and avoid the burdens of of a gastrostomy tube (G-tube) or prolonged home nasogastric ...

What is the current status of trial NCT07049952?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2025-11-16. Estimated completion is 2027-12-30.

What conditions does trial NCT07049952 study?

This clinical trial studies the following conditions: Feeding Delays, Neonates and Term Infants.

What interventions are being tested in trial NCT07049952?

The interventions under investigation include: taVNS (DEVICE), NAC and taVNS (COMBINATION_PRODUCT), inactive taVNS (DEVICE), sterile water and inactive taVNS (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT07049952?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07049952 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT07049952's enrollment target sits among peer trials

88 803rd of 2000 higher than 1,191 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07049952, the US trial registry maintained by the National Library of Medicine. NCT07049952 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.